Open Access1′‐Phenyl‐2′,3′,5′,6′,7′,7a′‐hexahydroindan‐2‐spiro‐2′‐1 H ‐pyrrolizine‐3′‐spiro‐11′‐indeno[1,2‐ b ]quinoxaline‐1,3‐dione. Corrigendum
Author(s) -
Gayathri D.,
Aravindan P. G.,
Velmurugan D.,
Ravikumar K.,
Sureshbabu A. R.
Publication year - 2005
Publication title -
acta crystallographica section e
Language(s) - English
Resource type - Journals
ISSN - 1600-5368
DOI - 10.1107/s1600536805032939
Subject(s) - quinoxaline , medicinal chemistry , chemistry , organic chemistry
In the paper by Gayathri, Aravindan, Velmurugan, Ravikumar & Sureshbabu [ Acta Cryst. (2005), E61, o3124o3126 ], the formula is given incorrectly in the Abstract . The correct formula is C 35 H 25 N 3 O 2 .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom